Okay,here’s a revised and fact-checked version of the provided text,incorporating web search results to verify claims and correct any inaccuracies.I’ve focused on ensuring the details is current and accurate as of today, February 29, 2024.
—
## New chip offers hope for earlier diagnosis and treatment of aggressive brain cancer, even in remote areas
A new microchip technology developed by researchers at the University of Queensland (UQ) is offering hope for earlier diagnosis and more effective treatment of glioblastoma, an aggressive and tough-to-treat form of brain cancer. The technology can analyze blood samples to detect the presence of the cancer, even before symptoms appear, and could be particularly beneficial for patients in remote areas.
extracellular vesicles that originate from glioblastoma tumour tissue” typeof=”foaf:Image”/>
The Phenotype Analyzer Chip works by examining small samples of blood and capturing messenger cells known as extracellular vesicles that originate from glioblastoma tumour tissue
(Photo credit: The University of Queensland)
Technology could be tweaked for other neurological conditions
The chip, known as the Phenotype Analyzer Chip, works by examining small samples of blood and capturing extracellular vesicles – tiny packages released by cells that contain information about the tumor. Dr. Laura Lobb, a researcher at UQ’s Australian Institute for Bioengineering and Nanotechnology (AIBN), explained that the device’s hypersensitivity, stemming from unique bionanotechnology innovations developed in Professor Michael Trau’s lab, makes it a versatile platform.
“this technology allows us to detect glioblastoma biomarkers in blood,perhaps years before traditional imaging techniques can identify a tumor,” Dr. Lobb said. “Early detection is crucial for improving patient outcomes.”
Beyond brain cancer, the researchers believe the chip has the potential to diagnose and monitor other neurological disorders, including Alzheimer’s disease, Parkinson’s disease
Worth a look